HCPCS code S0119 – Testosterone cypionate injection

Key Takeaways

HCPCS Code S0119 describes an injection of testosterone cypionate, billed per cc, used by Medicaid and commercial plans rather than Medicare fee-for-service.

S-series codes are not recognized by traditional Medicare; always verify payer-specific acceptance before submitting a claim.

Prior authorization is required by many commercial payers and Medicaid managed care organizations for S0119; missing PA is the most common denial trigger.

Pabau’s claims management software supports HCPCS code entry, modifier attachment, and diagnosis pointer linkage to reduce front-end rejections on S-series claims.

HCPCS Code S0119: descriptor and code category

HCPCS Code S0119 describes a single-milliliter injection of testosterone cypionate. The full descriptor reads: Injection, testosterone cypionate, per cc. Testosterone cypionate is a long-acting, oil-based ester of testosterone administered intramuscularly, typically in a clinic, physician office, or outpatient setting. The code is a unit code: each billed unit represents one cc of the formulation administered. If 200 mg (2 cc) is administered, the claim should reflect two units of S0119.

S0119 sits within the HCPCS Level II S-series, which spans codes S0000 through S9999. The S-series is maintained by commercial insurers, not by CMS, which is why these codes do not appear on the Medicare Physician Fee Schedule. Practices treating Medicare beneficiaries for testosterone deficiency must use the appropriate CPT drug administration code instead.

Which payers accept HCPCS Code S0119?

S-series HCPCS codes are not recognized by traditional Medicare fee-for-service. Submitting S0119 on a claim for a Medicare beneficiary will result in an automatic rejection. Medicaid managed care organizations and commercial plans are the primary payers for this code, though acceptance varies by state Medicaid agency and individual plan contract.

Before submitting a claim with HCPCS Code S0119, verify coverage through the payer’s provider portal or by calling the eligibility and benefits line. Many plans that cover testosterone replacement therapy have added S0119 to their fee schedules, but that acceptance is never universal. Understanding how medical billing works across different payer types is the foundation for avoiding rejections on S-series codes.

Prior authorization requirements for S0119

Many commercial payers and Medicaid managed care organizations require prior authorization (PA) before reimbursing claims with S0119. PA requirements are not uniform: a plan that covers testosterone injections without PA for one patient population may require it for another based on diagnosis, patient age, or treatment history. Always check the payer’s current prior authorization grid before the first administration.

The following documentation typically supports a PA request for S0119:

• Laboratory results confirming low serum testosterone levels (with reference ranges noted)
• Clinical documentation of signs and symptoms consistent with hypogonadism or testosterone deficiency
• Prescribing provider’s credentials and NPI
• Treatment plan including dosage, frequency, and expected duration
• Evidence of any formulary-required step therapy (e.g., prior trial of a lower-cost formulation)

If a PA is denied, the plan must provide written notice with the specific clinical rationale. First-level appeals typically require a peer-to-peer review request, submitted within the payer’s deadline (often 30-60 days from the denial date). Second-level appeals require a formal written submission that includes additional clinical literature supporting medical necessity. Document every submission date and reference number.

How to document S0119 correctly

A complete medical record entry for HCPCS Code S0119 must show that the service was medically necessary and that all billing elements can be verified by an auditor. Incomplete documentation is the second most common reason S0119 claims are denied after missing prior authorization.

Following medical billing compliance standards, each encounter note should include:

• Diagnosis linkage: the ICD-10-CM code(s) that establish hypogonadism or a related condition, pointed directly to S0119 on the claim form
• Drug and dosage: name of the drug (testosterone cypionate), concentration (e.g., 200 mg/mL), total volume administered in cc, and lot number if required by state law
• Route and site: intramuscular injection, anatomical site (e.g., gluteus medius, deltoid), and laterality
• Provider credentials: administering provider’s name, NPI, and role (e.g., RN, MA under physician supervision)
• Date and place of service: match the POS code on the claim (office = 11; outpatient hospital = 22)
• Supervising physician: name and NPI if the injection was administered by an ancillary staff member

Pabau’s claims management software supports structured injection encounter notes, automatic diagnosis pointer linkage, and HCPCS code entry with modifier fields, reducing the manual steps between clinical documentation and claim submission.

ICD-10 codes commonly used with S0119

Every S0119 claim requires at least one ICD-10-CM diagnosis code to establish medical necessity. The diagnosis pointer on the CMS-1500 (Box 24E) or the 837P electronic claim must link directly to S0119. Using an unsupported or overly broad diagnosis is a frequent cause of medical necessity denials.

Verify all ICD-10-CM codes against the current fiscal year tables published by the CDC/NCHS ICD-10-CM tool, as diagnosis codes are updated annually. A code valid in FY2024 may be revised or deleted in a subsequent year.

S0119 vs. related HCPCS codes: how to choose the right code

S0119 versus S0120 is the most common coding confusion in this range. S0120 describes an injection of testosterone cypionate and estradiol cypionate combined, a formulation used in hormone replacement therapy for some patients. Using S0120 when only testosterone cypionate is administered is an unbundling error and a medical necessity mismatch. Always confirm the product administered before selecting between these two codes.

For Medicare patients, use CPT code 96372 for the injection administration. The drug itself (testosterone cypionate) is then reported separately using the appropriate J-code if covered under Part B, or the patient’s Part D plan handles the pharmaceutical cost. Using HCPCS Code S0119 on a Medicare fee-for-service claim will result in an automatic payer rejection.

Reimbursement rates for HCPCS Code S0119

Reimbursement rates for S0119 are not set by a single national fee schedule. Because S-series codes fall outside the Medicare Physician Fee Schedule, each Medicaid agency and commercial plan establishes its own allowed amount. Rates reflect the plan’s drug acquisition cost plus an administration margin, and they vary substantially by geography and plan year.

General benchmarks based on Medicaid fee schedule data and commercial plan ranges (subject to change; always verify against your current payer contracts):

To obtain the most current rate, log into the AAPC Codify HCPCS lookup or your state Medicaid’s managed care organization’s provider portal. For commercial contracts, the allowed amount is specified in your fee schedule addendum. Never assume a rate from a prior year’s contract applies to the current plan year.

Common claim denial reasons for S0119 and how to fix them

Denied claims with S0119 follow predictable patterns. Proactive denial management starts with recognizing these triggers before the claim goes out the door.

How to appeal a denied S0119 claim

Appeals for denied S0119 claims follow a structured process. Acting on the correct deadline is critical: most commercial plans allow 90-180 days from the denial date to file a first-level appeal, while Medicaid managed care timelines vary by state contract.

1. Pull the explanation of benefits (EOB) or remittance advice: identify the exact CARC and RARC codes driving the denial.
2. Gather clinical documentation: lab results, treatment notes, prescribing provider’s assessment, and any PA approval letter if one was issued.
3. Draft a medical necessity letter: the treating provider should summarize the clinical rationale, citing the ICD-10-CM diagnosis, the lab values, and any applicable clinical guidelines (e.g., Endocrine Society guidelines on testosterone deficiency).
4. Submit within the deadline: include the original claim number, the denial date, and the clinical attachments. Send via certified mail or the payer’s online appeal portal.
5. Request peer-to-peer review if allowed: for medical necessity denials, a peer-to-peer call between the treating physician and the plan’s medical director often resolves the appeal faster than a written submission alone.
6. Escalate if denied again: file a second-level appeal or request an external independent review organization (IRO) review where required by state law.

Reduce HCPCS claim denials before they happen

Pabau’s claims management software handles HCPCS code entry, modifier attachment, diagnosis pointer linkage, and batch claim scrubbing so your S0119 claims go out clean the first time.

Book a demo

Billing S0119 in practice management software

Entering HCPCS Code S0119 correctly in a practice management or EHR system reduces the likelihood of a front-end rejection before the claim reaches the payer. A clean claim for S0119 requires accurate entry of the code, unit count, modifier, and diagnosis pointer at the point of charge capture, not as a post-submission correction.

Key steps when entering S0119 in a billing workflow:

1. Code entry: enter S0119 in the procedure code field. Confirm the system recognizes it as an HCPCS Level II code, not a CPT code. Some systems require a code type flag.
2. Unit count: set units to match the number of cc administered. Billing 1 unit when 2 cc were given will result in underpayment; billing 2 units when 1 cc was given is overcoding.
3. Modifier attachment: add any plan-required modifiers (e.g., GY, 25, or plan-specific modifiers). Confirm which modifiers your payer contract specifies for drug injection claims.
4. Diagnosis pointer: link the appropriate ICD-10-CM code(s) from the encounter to S0119 in the diagnosis pointer field (Box 24E on CMS-1500). Missing pointer = automatic denial.
5. Batch claim scrubbing: run the claim through your clearinghouse or built-in scrubber before submission. A scrubber flags missing modifiers, unit count mismatches, and invalid code combinations before they reach the payer.

For practices managing testosterone replacement therapy patients at volume, men’s health clinic software that integrates HCPCS code entry with clinical note templates and automated eligibility checks reduces per-claim processing time and catches unit-count errors at the charge entry stage. Look for a system that supports end-to-end claims management, from charge capture through ERA posting.

Conclusion

HCPCS Code S0119 is a straightforward drug injection code when payer acceptance and prior authorization are confirmed upfront. The most expensive billing errors on S0119 claims, including missing PA, incorrect unit counts, and mismatched diagnosis codes, are all preventable at the point of charge entry rather than recoverable after a denial.

Practices billing S0119 at volume should audit their claim templates, PA tracking workflows, and diagnosis pointer processes quarterly. Pabau’s claims management tools support structured HCPCS code entry, automated scrubbing, and ERA reconciliation to keep S0119 claims moving cleanly through the revenue cycle. To see how Pabau handles HCPCS billing workflows end to end, book a demo.

Continue your research

Need a foundation in medical billing before tackling S-series codes? What is medical billing covers the end-to-end revenue cycle, from charge capture to payment posting.

Facing a wave of denials? Denial management in healthcare outlines a systematic process for categorizing, appealing, and preventing recurring claim denials.

Want to understand claim file standards? The 837 electronic claim file guide explains how HCPCS codes, diagnosis pointers, and modifiers are structured in the 837P transaction.

Frequently Asked Questions